Researchers found that only a small proportion of CD8+ TILs in tumors could recognize tumor mutation-associated antigens, while another population (bystander cells) was insensitive, and differential CD39 expression was the key molecule that distinguished the two populations [86]. Here, CD8A is linked to neoplasm.